Autopsy report · NCT04032717
Griffithsin-based Rectal Microbicide for PREvention of Viral ENTry (PREVENT)
Cause of deathStaffing, sites or logistics
“Due to the COVID-19 pandemic, study enrollment has been prematurely terminated.”
Life of this trial
- Registered 3 months before it started.
- Ran for about 1 year 7 months before it stopped.
- 18 participants enrolled.
- No results are posted on the registry.
Vital statistics
- Status
- Terminated
- Phase
- Phase 1
- Sponsor
- Rhonda Brand
- Sponsor type
- University, hospital or other
- Conditions
- HIV Prevention
- Interventions
- Q-Griffithsin (Q-GRFT) enema; Placebo enema
- Participants
- 18
- Sites
- 1
- Countries
- United States
Trials that died the same way
- Changing Developmental Trajectories Through Early Treatment
“Participant enrollment was hindered by the COVID-19 pandemic and the study was ultimately terminated.” - Treatment Resistance Following Anti-cancer Therapies
“Study terminated due to lack of enrollment that has been compounded by the global COVID-19 pandemic. There were no safety and/or efficacy concerns involved in the decision to stop enrollment.” - Oral Immunotherapy for Desensitization in Children, Adolescents, and Young Adults With Hen Egg Allergy
“The study was prematurely terminated by the Sponsor based on difficulties in meeting enrollment goals, especially during the COVID-19 pandemic, and not for reasons relating to any concerns regarding quality, safety, or efficacy.” - Impact of App Based Diabetes Training Program in Conjunction With the BD Nano Pen Needle in People With T2 Diabetes
“Enrollment halted prematurely due to the Covid-19 pandemic” - Study to Evaluate the Efficacy and Safety of Moxifloxacin Versus Amoxicillin/Clavulanate in the Treatment of Acute Bacterial Rhinosinusitis
“The study was prematurely terminated due to slow enrollment beyond the planned study timelines.”
Look deeper
- The official registry record (the source of truth)
- Record history: every change the sponsor made
- Open it in the database
Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.